![Dina Chaya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dina Chaya
Directeur/Membre du Conseil chez
Oxular Ltd.
Profil
Dina Moghrabi Chaya is currently Director at Oxular Ltd. since 2016, Director at IFM Cinque, Inc., IFM Continua, Inc., and IFM Quattro, Inc. since 2021, Director at Oxular Acquisitions Ltd. since 2020, Director at Anjarium Biosciences AG since 2021, Partner at OrbiMed Advisors LLC, Partner at OrbiMed Advisors Private Equity since 2023, and Partner at Orbimed Advisors Private Equity since 2023.
Former roles include Non-Executive Director at The Monks Investment Trust Plc from 2022 to 2025, Director at 3i Venture Capital, Director at ENDOSENSE SA, Non-Executive Director at TopiVert Ltd. from 2013 to 2020, Director at Topivert Pharma Ltd. from 2013 to 2020, Independent Director at Wilson Therapeutics AB from 2015 to 2018, Independent Director at Imago BioSciences, Inc. from 2019 to 2023, Director at Attenua, Inc. from 2018 to 2020, Independent Director at Spruce Biosciences, Inc. from 2020 to 2023, Partner at NeoMed S.à.r.l.
from 2009 to 2023, Partner at Neomed Management (Jersey) Ltd. from 2014 to 2023, Partner at Omega Fund Management LLC from 2017 to 2023, and Member-Venture Capital Platform Council at Invest Europe VZW from 2018 to 2022.
Education includes undergraduate studies at the University of Cambridge and a doctorate from Université de Paris IV Paris-Sorbonne conferred in 1997.
Postes actifs de Dina Chaya
| Sociétés | Poste | Début |
|---|---|---|
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Operates as an eye drug development company | Directeur/Membre du Conseil | 01/02/2016 |
Oxular Acquisitions Ltd. | Directeur/Membre du Conseil | 01/08/2020 |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Directeur/Membre du Conseil | 01/10/2021 |
IFM Cinque, Inc.
 IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Directeur/Membre du Conseil | 01/10/2021 |
IFM Continua, Inc.
 IFM Continua, Inc. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | 01/10/2021 |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Directeur/Membre du Conseil | 01/08/2021 |
Orbimed Advisors Private Equity/UK/
 Orbimed Advisors Private Equity/UK/ Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/06/2023 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 01/06/2023 |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Private Equity Investor | - |
Anciens postes connus de Dina Chaya
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Dina Chaya
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
The Monks Investment Trust Plc
 The Monks Investment Trust Plc Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris IV Paris-Sorbonne
 Université de Paris IV Paris-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoMed S.à.r.l.
 NeoMed S.à.r.l. Investment ManagersFinance Functions as an alternative investment manager | Finance |
3i Venture Capital
 3i Venture Capital Investment ManagersFinance 3i VC is an active manager which works as a global team to select approximately twenty early- to late-stage investments per year. They aim to invest in companies with exceptional leadership, entrepreneurial flair, proven technical and business expertise, innovative technology and the vision to create a new market or gain significant share of an existing market. The firm prefers to lead or co-lead investments, and selects opportunities where they can create and realize significant value, take board seats and achieve exits via trade sales or IPOs. They target the healthcare, communications, software and ESAT (electronics, semiconductors and advanced technologies) sectors in Europe, the US and Asia. They invest in a series of funding rounds, separating 'first investments' (in businesses where 3i is not already invested) and 'further investments'. 3i VC actively supports their investee companies, making introductions and offering strategic guidance to accelerate their success. The majority of the firm's venture capital investment is made directly from 3i's balance sheet. | Finance |
ENDOSENSE SA
 ENDOSENSE SA Medical SpecialtiesHealth Technology Operates as a medical technology company which focuses on reproducibility of catheter ablation for the treatment of cardiac arrhythmias | Health Technology |
Neomed Management (Jersey) Ltd.
 Neomed Management (Jersey) Ltd. Investment ManagersFinance Alternative investment manager | Finance |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
TopiVert Ltd.
 TopiVert Ltd. BiotechnologyHealth Technology Provides treatments for inflammatory diseases of the eye and gut | Health Technology |
Topivert Pharma Ltd.
 Topivert Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Operates as an eye drug development company | Health Technology |
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Invest Europe VZW
 Invest Europe VZW Investment ManagersFinance Operates as a private equity, venture capital and infrastructure investment company | Finance |
IFM Cinque, Inc.
IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
IFM Continua, Inc.
IFM Continua, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
IFM Quattro, Inc.
IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Oxular Acquisitions Ltd. | |
Anjarium Biosciences AG
Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Health Technology |
Orbimed Advisors Private Equity/UK/
Orbimed Advisors Private Equity/UK/ Investment ManagersFinance Functions as an alternative investment manager | Finance |
